Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)

Kobayashi Pharmaceutical Income Statement

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	161,482	165,600	173,455	166,258	155,252	150,514
Revenue Growth (YoY)	-6.64%	-4.53%	4.33%	7.09%	3.15%	-10.44%
Cost of Revenue	78,491	77,997	77,079	73,927	66,478	65,248
Gross Profit	82,991	87,603	96,376	92,331	88,774	85,266
Selling, General & Admin	46,251	48,040	57,457	53,902	52,072	50,114
Research & Development	9,109	9,109	9,004	8,327	7,522	7,338
Other Operating Expenses	753	753	930	767	718	729
Operating Expenses	61,020	62,893	70,749	65,825	62,823	59,457
Operating Income	21,971	24,710	25,627	26,506	25,951	25,809
Interest Expense	-23	-28	-29	-18	-18	-21
Interest & Investment Income	852	815	762	578	588	747
Currency Exchange Gain (Loss)	-336	330	40	231	481	-216
Other Non Operating Income (Expenses)	1,208	1,033	930	983	1,011	1,407
EBT Excluding Unusual Items	23,672	26,860	27,330	28,280	28,013	27,726
Gain (Loss) on Sale of Investments	745	635	436	-89	84	261
Gain (Loss) on Sale of Assets	6	-51	-59	-52	-70	-64
Asset Writedown	-	-	-59	-69	-309	-1,122
Other Unusual Items	-8,515	-13,531	-89	-121	-83	-166
Pretax Income	15,908	13,913	27,559	27,949	27,635	26,635
Income Tax Expense	4,109	3,842	7,221	7,927	7,920	7,430
Earnings From Continuing Operations	11,799	10,071	20,338	20,022	19,715	19,205
Minority Interest in Earnings	-1	-4	-	-	-	-
Net Income	11,798	10,067	20,338	20,022	19,715	19,205
Net Income to Common	11,798	10,067	20,338	20,022	19,715	19,205
Net Income Growth	-15.18%	-50.50%	1.58%	1.56%	2.66%	0.34%
Shares Outstanding (Basic)	74	74	76	77	78	78
Shares Outstanding (Diluted)	74	74	76	77	78	78
Shares Change (YoY)	-0.83%	-1.98%	-1.67%	-1.27%	-0.05%	-0.32%
EPS (Basic)	158.71	135.42	268.16	259.61	252.35	245.70
EPS (Diluted)	158.71	135.42	268.16	259.59	252.35	245.70
EPS Growth	-14.47%	-49.50%	3.30%	2.87%	2.71%	0.67%
Free Cash Flow	10,013	-14,810	5,604	17,167	18,756	20,191
Free Cash Flow Per Share	134.69	-199.22	73.89	222.57	240.08	258.32
Dividend Per Share	59.000	102.000	101.000	90.000	83.000	77.000
Dividend Growth	-41.58%	0.99%	12.22%	8.43%	7.79%	5.48%
Gross Margin	51.39%	52.90%	55.56%	55.54%	57.18%	56.65%
Operating Margin	13.61%	14.92%	14.77%	15.94%	16.71%	17.15%
Profit Margin	7.31%	6.08%	11.72%	12.04%	12.70%	12.76%
Free Cash Flow Margin	6.20%	-8.94%	3.23%	10.33%	12.08%	13.41%
EBITDA	30,450	32,732	31,684	31,864	30,786	29,915
EBITDA Margin	18.86%	19.77%	18.27%	19.16%	19.83%	19.88%
D&A For EBITDA	8,479	8,022	6,057	5,358	4,835	4,106
EBIT	21,971	24,710	25,627	26,506	25,951	25,809
EBIT Margin	13.61%	14.92%	14.77%	15.94%	16.71%	17.15%
Effective Tax Rate	25.83%	27.61%	26.20%	28.36%	28.66%	27.90%
Advertising Expenses	-	11,575	23,038	22,389	22,499	21,608

Source: S&P Global Market Intelligence. Standard template. Financial Sources.